Formula Pharmaceuticals appoints Malcolm K. Brenner to scientific advisory board May 5, 2016 CenterWatch Staff
EMA grants accelerated assessment for BioMarin’s cerliponase alfa for Batten disease May 3, 2016 CenterWatch Staff